DZZOM - The Network Medicine Company

DZZOM reduces the cost and time of drug/biomarker development by integrating biopharma R&D data into networks and unlock to potential of Precision Medicine!

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Boston, MA, US
  • Currency USD
  • Founded November 2014
  • Employees 4
  • Website dzzom.com

Company Summary

DZZOM-The Network Medicine Company is a seed-stage bioinformatics startup company active in the field of network-driven analytics of biomedical data. DZZOM is in the forefront of using network sciences for the assessment of biopharma data and knowledge.
We introduce DZZOMAT SaaS platform enabling biopharma industry to perform standardized/validated Network Medicine workflows, and we enter into strategic partnerships to run inhouse programs.

Team

  • Marcell Veidner
    Founder

    - IE Master in Biotechnology Management 2011 alumnus.
    - Managing partner of Bionity Investment Advisors (2007-), a transaction oriented consultancy firm focusing on life sciences.
    - Director of the CEE activities at PCA Capital Advisors (2005-2007).
    - Director at the Hungarian Investment and Trade Development Agency, ITDH (2002-2005).
    - Board Member of the Hungarian Biotechnology Association
    - Member of the SME Platform of EuropaBio.

  • Péter Ruppert
    Founder

    Owner - Maven7
    Maven7 integrates the latest results of network research into its organizational, business and media analysis and solutions.
    - PR and regulatory affairs - manager
    British American Tobacco:
    -Senior account executive at kirowski -Isobar.
    I was responsible for online/digital marketing strategy planning and implementation for the major client's of Kirowski-Isobar, inc. Audi, Coca-Cola, Raiffeisen, Saatchi&Saatchi, Sara Lee

  • Albert László Barabási
    Founder, Member of the Scientific Advisory Board

    He is the former Emil T. Hofmann professor at the University of Notre Dame and current Distinguished Professor and Director of Northeastern University's Center for Complex Network Research (CCNR) and an associate member of the Center of Cancer Systems Biology (CCSB) at the Dana Farber Cancer Institute, Harvard University. He introduced the concept of diseasome, showing how diseases link to each other through shared genes.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free